Henry Ford Health System, 2799 W Grand Blvd.

2799 West Grand Boulevard
Detroit, Michigan 48202

We've found

1 trials

at this facility

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Detroit, MI

Use our guide to learn which trials are right for you!